米托蒽醌(MIT),mitoxantone(MIT)
1)mitoxantone(MIT)米托蒽醌(MIT)
2)mitoxantrone米托蒽醌
1.Preparation and optimization of mitoxantrone solid lipid nanoparticles by central composite design;米托蒽醌固体脂质纳米粒的制备与处方优化
2.Studies on preparation of folate-conjugated mitoxantrone-loaded albumin nanoparticles and its property in vitro;叶酸偶联米托蒽醌白蛋白纳米粒的制备及体外性质研究
3.Studies on the Voltammetric Behavior of Mitoxantrone and Its Application at the Ni/GC Modified Electrode;米托蒽醌在离子注入修饰电极上的伏安行为及其应用
英文短句/例句

1.Preparation of PLA-PLL-RGD Nanoparticles Loaded with Mitoxantrone载米托蒽醌PLA-PLL-RGD纳米粒的制备
2.Comparing study of acute and delayed toxicity of mitoxantrone-polybutycyanoacrylate-nanosphere and mitoxantrone肝靶向药物米托蒽醌毫微球与米托蒽醌急性及延迟毒性的比较研究
3.The Effects of Aclarubicin on Mitoxantrone Killing of Hela Cells;阿克拉霉素对米托蒽醌杀伤Hela细胞的影响
4.Study for security evaluation of Mitoxantrone Hydrochloride and Sodium Chloride Injection盐酸米托蒽醌氯化钠注射液安全性评价
5.Curative effect of Mitoxantrone plus Thalidomide and Dexamethasone on treatment of multiple myeloma米托蒽醌联合沙利度胺、地塞米松治疗多发性骨髓瘤的疗效评价
6.The Clinical Efficacy of DDP, MIT and CTX on the Treatment of Pleura Metastasis of Breast Cancer顺铂、米托蒽醌及环磷酰胺联合治疗乳腺癌胸膜转移的临床疗效
7.Mitoxantrone Ethylcellulose Microspheres for Liver Arte-rial Embolization肝动脉栓塞米托蒽醌乙基纤维素微球的制剂学研究
8.Investigation on the Tumor Cell Active Targeting Characteristics of Mitoxantrone-Insulin Conjugate;肿瘤细胞主动靶向米托蒽醌-胰岛素偶联物的研究
9.The Combination of Mitoxantrone and Cytarabine in treatment of 30 patients with Acute Non-lymphocytic Leukemia米托蒽醌和阿糖胞苷方案治疗急性非淋巴细胞白血病30例
10.Study on Folate Receptor-mediated Mitoxantrone Albumin Nanoparticles Drug Delivery System Targeting for Ovarian Cancer Cell;叶酸受体介导的米托蒽醌白蛋白纳米粒靶向卵巢癌细胞给药系统的研究
11.Thalidomide in Combination with Fludarabine,Mitoxantrone,Dexamethasone in the Treatment of Patients with Chronic Lymphoprolifcrative Disorders:Report of Six Cases沙利度胺联合氟达拉滨、米托蒽醌与地塞米松治疗慢性淋巴细胞增殖性疾病6例
12.Experimental Studies on Therapeutic Effect and Mechanism of Brucea Javanica Emulsion Associated with Mitoxantrone for Hormone Refractory Prostate Cancer(HRPC);鸦胆子油乳联合米托蒽醌对激素抵抗性前列腺癌的作用及机制研究
13.The Experimental Research on Calreticulin Exposure in Mouse Melanoma Cell Line B16 by Using Epirubicin、Mitoxantone and 5-fluorouracil表阿霉素、米托蒽醌及5-氟尿嘧啶对B16细胞膜表面钙网蛋白表达影响的实验研究
14.Photocatalytic degradation of anthraquinone dye wastewater with nano-TiO_2/diatomite纳米TiO_2/硅藻土光催化降解蒽醌染料废水的研究
15.anthracene brown蒽棕(直接蒽醌染料)
16.anthraquinone-2-sulfonic acid sodium salt蒽醌-2-磺酸钠盐
17.Content determination of total anthraquinones in Zhi Kangtai nanoparticles by HPLC gradient elutionHPLC梯度洗脱测定痔康泰纳米粒中大黄蒽醌成分的总含量
18.anthraquinonediazonium chloride zinc chloride compound蒽醌重氮氯化锌复合物
相关短句/例句

mitoxantrone米托蒽醌
1.Preparation and optimization of mitoxantrone solid lipid nanoparticles by central composite design;米托蒽醌固体脂质纳米粒的制备与处方优化
2.Studies on preparation of folate-conjugated mitoxantrone-loaded albumin nanoparticles and its property in vitro;叶酸偶联米托蒽醌白蛋白纳米粒的制备及体外性质研究
3.Studies on the Voltammetric Behavior of Mitoxantrone and Its Application at the Ni/GC Modified Electrode;米托蒽醌在离子注入修饰电极上的伏安行为及其应用
3)mitoxantrone(DHAQ)米托蒽醌(DHAQ)
4)mitoxantrone hydrochloride盐酸米托蒽醌
1.Method: To prepare the transfersomes of colchicines(CLC),vincristine sulfate(VCR) and mitoxantrone hydrochloride(DHAD) with the same materials and methods,and then measure their EE.方法:采用相同的原料和方法制备了秋水仙碱(CLC)、硫酸长春新碱(VCR)和盐酸米托蒽醌(DHAD)的传递体(CLC-T,VCR-T,DHAD-T)并测定包封率,探讨了药物的溶解性、分子质量和电性等与包封率的关系;进行传递体体外释放实验,比较不同药物传递体体外释放的差异。
2.A HPLC method was established for the determination of the entrapment efficiency of the liposomes loaded with vincristine sulfate and mitoxantrone hydrochloride.建立了HPLC法测定硫酸长春新碱和盐酸米托蒽醌复方脂质体的包封率。
3.A flow injection chemiluminescence(FI-CL) system for determination of mitoxantrone hydrochloride was presented.在酸性条件下,甲醛与高锰酸钾能够产生较弱的化学发光,而盐酸米托蒽醌能够大大地增强该化学发光强度。
5)Mitoxantrone盐酸米托蒽醌
1.Structure Charateristics of Mitoxantrone Transforsomes;盐酸米托蒽醌传递体的包结机理研究
2.Study on preparation and release of mitoxantrone transfersomes in vitro;盐酸米托蒽醌传递体的制备及制剂学性质研究
6)Mitoxantrone HCI盐酸米托蒽醌 ,米托蒽醌,能减瘤, 二羟基蒽醌, 丝裂蒽醌, 米西宁
延伸阅读

米托蒽醌分子式:C22H28O4O6·2HCL分子量:516.99CAS号:65271-80-9性质:蓝黑色结晶。熔点203-205℃。略溶于水,微溶于乙醇,不溶于氯仿和丙酮。无臭,易吸潮制备方法:参见参考文献。用途:蒽环类抗癌药,抗癌活性与阿霉素相似或略高,明显高于环磷酰胺、阿糖胞苷、甲氨喋呤、氟脲嘧啶、长春新碱等常用的抗癌药。临床用于乳腺癌有突出的疗效。
imtoken助记词怎么填-imtoken钱包没有收益-imtoken矿工费太贵了-im钱包官网:token.im